Mice Model Technologies Market [2028]: Size, Share - Competitive Intelligence Report - TechSci Research

According to TechSci Research report, "Mice Model Technologies Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028", the Global Mice Model Technologies Market stood at USD 1.22 Billion in 2022 and is anticipated to grow with a CAGR of 10.23% through 2028. Due to increasing utilization of mice models for personalized drug production, the global mice model market is likely to expand rapidly during the forecast period. Besides, increasing investments in research and development activities in the pharmaceutical & biotechnology sector is another factor expected to augment the global mice model market during the forecast period. Moreover, the rising use of mice models in the production of monoclonal antibodies is likely to fuel the global mice model market during the forecast period. However, during the forecast period, the global mice model market is expected to be restrained by the continuous discovery of substitute approaches for animal studies. In March 2021, Charles River Laboratories International, Inc. announced the acquisition of Cognate BioServices, Inc., a leading cell and gene therapy CDMO (contract development and manufacturing organization), to expand its cell and gene therapy offerings and capabilities.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Mice Model Technologies Market" - https://www.techsciresearch.com/report/mice-model-technologies-market/21443.html

In February 2021, The Jackson Laboratory and Nanjing Biotech Innovation Center (NBIC) announced a strategic partnership to provide mouse model breeding and technical services to researchers in China. In January 2021, Taconic Biosciences announced the expansion of its CRISPR gene editing capabilities to include rat models, in addition to mouse models.

The Global Mice Model Technologies Market is segmented into Technology, End User, and company.

Based on the Technology, the CRISPR Knockout technology segment is anticipated to witness substantial market growth throughout the forecast period. The ascent of CRISPR Knockout technology stands as a key driver propelling the growth of the Global Mice Model Technologies Market. CRISPR, an innovative genome editing tool, has revolutionized the precision and efficiency with which genetic modifications are introduced into mouse genomes. This breakthrough technology allows researchers to selectively "knock out" specific genes, creating genetically modified mice with targeted genetic alterations that mimic human diseases more accurately. The speed and cost-effectiveness of CRISPR Knockout technology have significantly accelerated the generation of customized mice models, reducing both research timelines and associated costs. The tool's versatility enables researchers to swiftly develop mouse models for a wide array of diseases, providing a robust platform for preclinical research in pharmaceuticals and biotechnology.

Based on the End Users segment, the Biotechnology Companies segment has been the dominant force in the market. Biotechnology companies are poised to be significant drivers of the growth in the Global Mice Model Technologies Market. As pioneers in drug discovery, development, and innovative therapeutic solutions, these companies heavily rely on mice models for preclinical research. The versatility of mice models in mimicking human diseases and testing novel therapies makes them indispensable assets for biotech firms aiming to bring groundbreaking treatments to market. Biotechnology companies leverage mice models for a range of applications, including studying disease mechanisms, evaluating drug efficacy and safety, and conducting personalized medicine research. With a growing emphasis on precision medicine, these firms increasingly seek tailored mice models to advance their understanding of specific genetic conditions and to develop targeted therapeutics.



Major companies operating in Global Mice Model Technologies Market are:

Biocytogen LLC
Charles River Laboratories Inc.
Cyagen Biosciences.
GemPharmatech Co Ltd.
genOway S.A.
Ingenious Targeting Laboratory Inc.
Merck KGaA.
Ozgene Pty Ltd.
Taconic Biosciences Inc.
Polygena AG


Download Free Sample Report - https://www.techsciresearch.com/sample-report.aspx?cid=21443

"The market prospects have been driven by factors such as technological advancements over the analysis period. Advancements in technology have made it easier to manipulate the genes of mice models and create specific genetic modifications that mimic human diseases. This has opened up new avenues for research and drug development. The development of new techniques such as CRISPR/Cas9 gene editing has made it easier to create more precise and accurate mice models, which has further increased their utility in research. " said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

"Mice Model Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology (CRISPR Knockout, Random Insertions, Large, Targeted Insertions, ES Cell Modification (Homologous Recombination), Others), By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research And Manufacturing Organizations), By Region, By Competition", has evaluated the future growth potential of Global Mice Model Technologies Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Mice Model Technologies Market.

Download Free Sample Report - https://www.techsciresearch.com/sample-report.aspx?cid=21443

Table Of Content:

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Mice Model Technologies Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Technology (CRISPR Knockout, Random Insertions, Large, Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)

5.2.2. By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research And Manufacturing Organizations)

5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.4. By Company (2022)

5.3. Market Map

5.3.1 By Technology

5.3.2 By End Users

5.3.3 By Region

6. North America Mice Model Technologies Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Technology (CRISPR Knockout, Random Insertions, Large, Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)

6.2.2. By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research And Manufacturing Organizations)

6.2.3. By Country

6.3. North America: Country Analysis

6.3.1. United States Mice Model Technologies Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Technology

6.3.1.2.2. By End Users

6.3.2. Canada Mice Model Technologies Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Technology

6.3.2.2.2. By End Users

6.3.3. Mexico Mice Model Technologies Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Technology

6.3.3.2.2. By End Users

7. Europe Mice Model Technologies Market Outlook

..........................

Download Free Sample Report - https://www.techsciresearch.com/sample-report.aspx?cid=21443

Contact Techsci Research-
US -
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com/

TechSci Research is a research based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries.

TechSci Research's core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci's client leads rather than follow market trends. Not bound by legacy, TechSci's cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

This release was published on openPR.